BamSEC and AlphaSense Join Forces
Learn More

KALA BIO Inc.

NASDAQ: KALA    
Share price (1/8/25): $6.82    
Market cap (1/8/25): $31.4 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 8 pages Certificate of Designations, Preferences and Rights of Series I Convertible Non-Redeemable Preferred Stock of KALA Bio, Inc
12/34/56
EX-3.1
from 10-Q 56 pages Restated Certificate of Incorporation of Kala Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 8 pages Certificate of Designations, Preferences and Rights of Series H Convertible Non-Redeemable Preferred Stock of Kala Bio, Inc
12/34/56
EX-3.1
from 10-K 52 pages Restated Certificate of Incorporation of Kala Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 8 pages ​ Certificate of Designations, Preferences and Rights of Series G Convertible Non-Redeemable Preferred Stock of Kala Bio, Inc. ​ (Pursuant to Section 151 of the Delaware General Corporation Law) ​
12/34/56
EX-3.1
from 8-K 8 pages Certificate of Designations, Preferences and Rights of Series F Convertible Non-Redeemable Preferred Stock of Kala Bio, Inc
12/34/56
EX-3.1
from 10-Q 32 pages Restated Certificate of Incorporation of Kala Pharmaceuticals, Inc
12/34/56
EX-3.2
from 8-K 22 pages Third Amended and Restated By-Laws of Kala Bio, Inc. ​
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to Restated Certificate of Incorporation of Kala Pharmaceuticals, Inc
12/34/56
EX-3.2
from 10-Q 22 pages Stockholders
12/34/56
EX-3.1
from 10-K 29 pages Restated Certificate of Incorporation of Kala Pharmaceuticals, Inc
12/34/56
EX-3.2
from 8-K 1 page Kala Pharmaceuticals, Inc. Certificate of Elimination of Number of Shares of Preferred Stock Designated as Series D Preferred Stock Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 8-K 7 pages Certificate of Designations, Preferences and Rights of Series E Convertible Non-Redeemable Preferred Stock of Kala Pharmaceuticals, Inc
12/34/56
EX-3.2
from 10-Q 22 pages Amended and Restated By-Laws of Kala Pharmaceuticals, Inc
12/34/56
EX-3.1
from 10-Q 20 pages Restated Certificate of Incorporation of Kala Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 3 pages ​ Certificate of Amendment of Restated Certificate of Incorporation of Kala Pharmaceuticals, Inc
12/34/56
EX-3.2
from 8-K 1 page Amendment to the Amended and Restated By-Laws of Kala Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-A12G 6 pages ​ Kala Pharmaceuticals, Inc. ​ Certificate of Designation of Series D Preferred Stock Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.2
from 8-K 28 pages Stockholders
12/34/56
EX-3.1
from 8-K 10 pages Restated Certificate of Incorporation of Kala Pharmaceuticals, Inc
12/34/56